Phagos
FranceEntry
2025
Hold
1yr
Status
Active
Who owns Phagos?
Phagos is a French Biotech company, currently owned by CapHorn since 2025 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
All Iron VenturesAcurio Ventures Fund III · 2024 · VC
4 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Key takeaways
- ·Co-held by CapHorn, Citizen Capital, Capagro and All Iron Ventures since 2025.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2025 · present
CapHornActive
2025 · present(1yr) · CapHorn 2 · 2017 · VC
All Iron VenturesActive
2025 · present(1yr) · Acurio Ventures Fund III · 2024 · VC
CapagroActive
2025 · present(1yr) · Capagro Agri-Food Innovation Fund II · 2022 · VC
Citizen CapitalActive
2025 · present(1yr) · Citizen Capital Fund III · 2022 · Growth
More from Acurio Ventures Fund III
Other portfolio companies in the same fund.
Germany
Spain
Italy
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Phagos?
Phagos is currently owned by CapHorn, Citizen Capital and 2 others, through Acurio Ventures Fund III, since 2025.
When did CapHorn and 3 others acquire Phagos?
CapHorn and 3 others acquired Phagos in 2025.
Who has owned Phagos over time?
Phagos has been through 4 private-equity ownership periods: CapHorn · via CapHorn 2 · since 2025; Citizen Capital · via Citizen Capital Fund III · since 2025; Capagro · via Capagro Agri-Food Innovation Fund II · since 2025; All Iron Ventures · via Acurio Ventures Fund III · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue